Cell receptor complexes

In this reaction chain, ZAP kinase performs an essential function. Tlie phosphorylated ARAM motives recruit ZAP70 kinase to the T cell receptor complex and mediate high affinity binding to the kinase. The two SH2 domains of ZAP70 kinase bind in tandem fashion to the twice-phosphorylated ARAM motif ZAP70 kinase shows a complex pattern of Tyr phosphorylation, including phosphorylations with an inhibitory effect. 

Buschle, M., Cotton, M., Kirlappos, H., et al. (1995) Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex. Hum. Gene Ther., 6, 753-761. 

T-Cell Activation, T-Cell Receptor Complex and Signal Transduction... 

Borst, J., Jacobs, H., Brouns, G. (1996). Composition and function of T-cell receptor and B-cell receptor complexes on precursor lymphocytes. Cuir. Op. Immunol. 8,181-190. 

Murom onab Murine IgG2a CD3e Part of T-cell receptor complex Peptides presented by MHC on APCp>... 

M24. Mirro, J., Jr., Kitchingman, G., Behm, F. G., Murphy, S. B., and Goorha, R. M., T cell differentiation stages identified by molecular and immunologic analysis of the T cell receptor complex in childhood lymphoblastic leukemia. Blood 69,908-912 (1987). 

Figure 33.29. T-Cell Receptor Complex. The T-cell receptor is associated with six CD3 molecules a CD3-y - CD3-e heterodimer, a CD3-5 - CD3-e heterodimer, and two chains of CD3-. Single ITAM sequences are present in the cytoplasmic domains of CD3-y, CD3-6, and CD3-e whereas three such sequences are found in each CD3- chain.

Thymocytes produced in the bone marrow do not express the T-cell-receptor complex, CD4, or CDS. On relocation to the thymus and rearrangement of the T-cell-receptor genes, the immature thymocyte expresses all of these molecules. These cells are first subjected to positive selection (Figure 33.43). Cells for which the T-cell receptor can bind with reasonable affinity to either class I or class II MHC molecules survive this selection those for which the T-cell receptor does not participate in such an interaction undergo apoptosis and die. The role of the positive selection step is to prevent the production ofT cells that will not bind to any MHC complex present, regardless of the peptide bound. 

Smith, C.A., Williams, G.T., Kingston, R., Jenkinson, E.J. and Owen, J.J. (1989) Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 337 181-184. 

Thymocytes produced in the bone marrow do not express the T-cell-receptor complex, CD4, or CDS. On relocation to the thymus and rearrangement of theT-cell-receptor genes, the immature thymocyte expresses all of these molecules. These cells are first subjected to positive selection... 

Maniolos, M. (1990). Transmembrane Helical Interactions and the Assembly of the T Cell Receptor Complex, ... 

Microcolumn reverse-phase HPLC electrospray ionization tandem mass spectrometry (ESI-MS/MS) is a rapid and sensitive technique for the analysis of complex mixtures of peptides. This technique is used to determine the amino acid sequence of unknown peptides, to verify the structure of proteins, and to determine posttrans-lational modifications (see also the article by Beth L. Gillece-Castro). In particular, the strength of this approach is the analysis of peptides in complicated mixtures, such as amino acid sequence analysis of peptides isolated from class I and II major histocompatibility T-cell receptor complexes (Hunt et al., 1992a). 

Perhaps the most astonishing aspect of this mAh is that it was used for the treatment of acute renal allograft rejection in patients only two years after being raised, on the basis of its ability to block CTLs in vitro, at a time when the structure of the T cell receptor complex was unknown (7). Although, even now it remains as an effective treatment for the reversal of steroid resistant acute allograft rejection, many of the compUcations associated with therapy were either underestimated or not anticipated. Nowadays extensive pre-clinical data is required, often involving primate studies, before a mAb can be used in clinical trials. It is likely that if mAbs to CDS were introduced today rather than in 1981 that they would not have gained a hcence for human use. Monoclonal antibodies to CDS in both human and animal studies have broadly similar effects and are of interest because they elicit many of the complications associated with mAb therapy. How these problems have been circumvented serves a framework for many other mAbs under development. 

CDS (T cell receptor complex) POPC and POPC/cholesterol/ sphingomyelin bilayers 95... 

The FBI has been shown to increase CD8 and to decrease CD4 on the thymic cells in the early stage of immune response. CD4 and CD8 are glycoproteins expressed on both the thymocytes and mature T cells, and act as co-receptors for T cell receptor complex (TCR7CD3) [35]. CD4 and CD8 bind to monomorphic MHC class II and class I determinants, respectively [8,13]. Ag-induced binding of TCR/CD3 and CD4 or CD8 leads to activation of PTK (that closely linked with CD4/8), stimulates the tyrosine phosphorylation, and activates the PLD and PKC [7,8,26,36,57]. TCR/CD3 activation causes distinct results in the thymus and spleen. In the immature thymocytes, this activation leads to the apoptosis or selection. In the mature T cells, this activation causes either the proliferation or the anergy that depends on co-stimulative signal [66]. 

---